HOME-CoV - Hospitalization or Outpatient ManagEment of patients with a proven or probable SARS-CoV-2 infection
Head :
DOUILLET Delphine
Last update : 02/03/2021 | Version : 1 | ID : 73649
| General | |
| Identification | |
| Detailed name | Hospitalization or Outpatient ManagEment of patients with a proven or probable SARS-CoV-2 infection |
| Sign or acronym | HOME-CoV |
| General Aspects | |
| Medical area |
Emergency medicine |
| Study in connection with Covid-19 |
Yes |
| Health determinants |
Healthcare system and access to health care services |
| Scientific investigator(s) (Contact) | |
| Name of the director | DOUILLET |
| Surname | Delphine |
| Delphine.Douillet@chu-angers.fr | |
| Collaborations | |
| Funding | |
| Funding status |
Public |
| Details | CHU Angers |
| Governance of the database | |
| Sponsor(s) or organisation(s) responsible | CHU Angers |
| Organisation status | |
| Additional contact | |
| loic.carballido@chu-angers.fr | |
| Main features | |
| Type of database | |
| Type of database |
Study databases |
| Study databases (details) |
Cohort study |
| Database recruitment is carried out by an intermediary |
A selection of health institutions and services |
| Database recruitment is is made on the basis of: |
Another treatment or procedure |
| Database recruitment is carried out as part of an interventional study |
Yes |
| Details |
Performed at group level (clusters) |
| Database objective | |
| Main objective |
the composite rate of adverse outcomes [ Time Frame: day 7 ]
Adverse outcomes include intubation with mechanical ventilation requirement and death (Stage ≥ 6 on "Ordinal Scale for Clinical Improvement" of the World Health Organization) within 7 days after inclusion. |
| Inclusion criteria |
The rate of hospitalization [ Time Frame: 24 hours ]
The rate of patients hospitalized after admission to the emergency room including patients discharged home more than 24 hours after admission. It will be analyzed in a hierarchical approach, only if first primary objective is positive i.e. non-inferiority of HOME-CoV strategy versus current practice on the rate of adverse outcomes. |
| Population type | |
| Age |
Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) Elderly (65 to 79 years) Great age (80 years and more) |
| Population covered |
Sick population |
| Pathology | J12 - Viral pneumonia, not elsewhere classified |
| Gender |
Male Woman |
| Geography area |
International |
| Detail of the geography area | France Belgium |
| Data collection | |
| Dates | |
| Size of the database | |
| Size of the database (number of individuals) |
[1000-10 000[ individuals |
| Details of the number of individuals | 4000 |
| Data | |
| Database activity |
Current data collection |
| Type of data collected |
Clinical data Declarative data Paraclinical data Biological data Administrative data |
| Clinical data (detail) |
Direct physical measures Medical registration |
| Declarative data (detail) |
Face to face interview Phone interview |
| Procedures | |
| Participant monitoring |
Yes |
| Monitoring procedures |
Monitoring by contact with the participant (mail, e-mail, telephone etc.) |
| Promotion and access | |
| Promotion | |
| Access |
